Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2020

GlobalData's Medical Devices sector report, "Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Reproductive Hormones and Proteins Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine function (such as the pancreas, liver, kidneys, and gonads) and affect the health and behavior of both males and females.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Reproductive Hormones and Proteins Tests under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Reproductive Hormones and Proteins Tests and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Reproductive Hormones and Proteins Tests under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

2 Introduction

3 Products under Development

4 Reproductive Hormones and Proteins Tests - Pipeline Products under Development by Companies

5 Reproductive Hormones and Proteins Tests Companies and Product Overview

6 Reproductive Hormones and Proteins Tests- Recent Developments

7 Appendix

List of Tables

List of Tables

• Table 1: Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
• Table 2: Reproductive Hormones and Proteins Tests - Pipeline Products by Segment
• Table 3: Reproductive Hormones and Proteins Tests - Pipeline Products by Territory
• Table 4: Reproductive Hormones and Proteins Tests - Pipeline Products by Regulatory Path
• Table 5: Reproductive Hormones and Proteins Tests - Pipeline Products by Estimated Approval Date
• Table 6: Reproductive Hormones and Proteins Tests Companies - Pipeline Products by Stage of Development
• Table 7: Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
• Table 8: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
• Table 9: AgPlus Diagnostic System - Testosterone Assay - Product Status
• Table 10: AgPlus Diagnostic System - Testosterone Assay - Product Description
• Table 11: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
• Table 12: Estradiol Assay - Product Status
• Table 13: Estradiol Assay - Product Description
• Table 14: Aura Biotechnologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Table 15: AURA Quant Anti-Mullerian hormone (AMH) ELISA Kit - Product Status
• Table 16: AURA Quant Anti-Mullerian hormone (AMH) ELISA Kit - Product Description
• Table 17: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 18: UniCel DxC 660i Synchron Access Clinical System - AMH Assay - Product Status
• Table 19: UniCel DxC 660i Synchron Access Clinical System - AMH Assay - Product Description
• Table 20: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 21: AFIAS-6 Progesterone Assay - Product Status
• Table 22: AFIAS-6 Progesterone Assay - Product Description
• Table 23: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• Table 24: Infertility Reagent Test kit - ECLIA Analyzer - Product Status
• Table 25: Infertility Reagent Test kit - ECLIA Analyzer - Product Description
• Table 26: Confer Health Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 27: Urine-Based-Test - Fertility Tracking - Product Status
• Table 28: Urine-Based-Test - Fertility Tracking - Product Description
• Table 29: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
• Table 30: Estradiol II Assay - Product Status
• Table 31: Estradiol II Assay - Product Description
• Table 32: Progesterone II Assay - Product Status
• Table 33: Progesterone II Assay - Product Description
• Table 34: Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Table 35: ESP-Based Diagnostic Test - Pregnancy - Product Status
• Table 36: ESP-Based Diagnostic Test - Pregnancy - Product Description
• Table 37: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
• Table 38: Lumipulse G1200 - AMH - Product Status
• Table 39: Lumipulse G1200 - AMH - Product Description
• Table 40: Lumipulse G1200 - Estradiol Assay - Product Status
• Table 41: Lumipulse G1200 - Estradiol Assay - Product Description
• Table 42: Genovum Sp. z o.o. Pipeline Products & Ongoing Clinical Trials Overview
• Table 43: Diagnostic Test - Polycystic Ovarian Syndrome - Product Status

List of Figures

List of Figures

• Figure 1: Reproductive Hormones and Proteins Tests - Pipeline Products by Stage of Development
• Figure 2: Reproductive Hormones and Proteins Tests - Pipeline Products by Segment
• Figure 3: Reproductive Hormones and Proteins Tests - Pipeline Products by Territory
• Figure 4: Reproductive Hormones and Proteins Tests - Pipeline Products by Regulatory Path
• Figure 5: Reproductive Hormones and Proteins Tests - Pipeline Products by Estimated Approval Date